Baseimmune Ltd
Company Profile
live
SmallBaseimmune Ltd
12289125•Private Limited With Share Capital
The London Bioscience Innovation, Royal College Street, London, NW10NH
Get Full Access
Incorporated
30/10/2019
Company Age
6 years
Directors
7
Employees
17
SIC Code
72110
Risk
very low risk
Company Overview
Registration, classification & business activity
Baseimmune Ltd (12289125) is a private limited with share capital incorporated on 30/10/2019 (6 years old) and registered in london, NW10NH. The company operates under SIC code 72110 and is classified as Small.
Baseimmune was founded in 2019 as a discovery phase start-up in the antigen discovery and vaccine development field.
Private Limited With Share Capital
SIC: 72110
Small
Incorporated 30/10/2019
NW10NH
17 employees
Financial Overview
Total Assets
£9.69M
Liabilities
£65.7K
Net Assets
£9.62M
Cash
£8.66M
Key Metrics
17
Employees
7
Directors
34
Shareholders
Board of Directors
5
Name
Position
director
director
director
director
director
Filed Documents
53
Document Name
Category
Date
Confirmation Statement With Updates
Category:Confirmation Statement
Date:12-11-2025
Change Person Director Company With Change Date
Category:Officers
Date:12-11-2025
Change Person Director Company With Change Date
Category:Officers
Date:12-11-2025
Appoint Person Director Company With Name Date
Category:Officers
Date:12-11-2025
Capital Cancellation Shares
Category:Capital
Date:07-11-2025
Capital Return Purchase Own Shares
Category:Capital
Date:07-11-2025
Capital Name Of Class Of Shares
Category:Capital
Date:01-10-2025
Capital Allotment Shares
Category:Capital
Date:01-10-2025
Termination Director Company With Name Termination Date
Category:Officers
Date:30-09-2025
Legacy
Category:Change Of Name
Date:16-09-2025
Capital Allotment Shares
Category:Capital
Date:12-09-2025
Resolution
Category:Resolution
Date:27-08-2025
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:27-08-2025
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:27-08-2025
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:27-08-2025
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:27-08-2025
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:29-07-2025
Capital Allotment Shares
Category:Capital
Date:06-12-2024
Change Account Reference Date Company Current Extended
Category:Accounts
Date:13-11-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:05-11-2024
Second Filing Capital Allotment Shares
Category:Capital
Date:04-11-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:17-07-2024
Memorandum Articles
Category:Incorporation
Date:27-01-2024
Resolution
Category:Resolution
Date:27-01-2024
Capital Allotment Shares
Category:Capital
Date:22-01-2024
Appoint Corporate Director Company With Name Date
Category:Officers
Date:22-01-2024
Memorandum Articles
Category:Incorporation
Date:09-11-2023
Resolution
Category:Resolution
Date:09-11-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:02-11-2023
Capital Allotment Shares
Category:Capital
Date:29-08-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:27-07-2023
Capital Allotment Shares
Category:Capital
Date:20-12-2022
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:31-10-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:15-07-2022
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:13-05-2022
Change Person Director Company With Change Date
Category:Officers
Date:28-04-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:01-11-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:30-09-2021
Capital Allotment Shares
Category:Capital
Date:28-09-2021
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:28-09-2021
Termination Director Company With Name Termination Date
Category:Officers
Date:28-09-2021
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:27-07-2021
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:14-07-2021
Resolution
Category:Resolution
Date:24-05-2021
Capital Allotment Shares
Category:Capital
Date:12-04-2021
Resolution
Category:Resolution
Date:12-04-2021
Capital Alter Shares Subdivision
Category:Capital
Date:06-04-2021
Memorandum Articles
Category:Incorporation
Date:06-04-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:22-03-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:22-03-2021
Capital Allotment Shares
Category:Capital
Date:22-03-2021
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:11-11-2020
Incorporation Company
Category:Incorporation
Date:30-10-2019
Innovate Grants
1
This company received a grant of £67841.4 for Vaxstable - Bringing Lipid Nanoparticle Based Mrna Vaccines In From The Cold. The project started on 01/12/2023 and ended on 31/03/2026.
Import / Export
Imports
12 Months6
60 Months14
Exports
12 Months2
60 Months3
Risk Assessment
very low risk
International Score
Future Factor
excellent
Performance Rating
Accounts
Typetotal exemption full
Due Date30/09/2026
Filing Date29/07/2025
Latest Accounts31/10/2024
Trading Addresses
Sir Alexander Fleming Building, Imperial College London, London, SW72AZ
The London Bioscience Innovation, 2 Royal College Street, London, NW10NHRegistered
Related Companies
10
Contact
baseimmune.co.uk
The London Bioscience Innovation, Royal College Street, London, NW10NH